Company: SHPH
Filing Date: 2025-02-27
Form Type: 424B3
Source: 0001493152-25-008474
Chunk: 139

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-27
Form: 424B3
Chunk 139
---
ology and as adjuvants for immunotherapy of cancers.

| 73 |

Joseph Armstrong, III, Ph.D.joined as a Scientific Advisor to Shuttle Pharmaceuticals in 2021, He received his Ph.D. from the University of Colorado in 1988, completed his post-doctoral work at the University of Virginia at Charlottesville and holds the position of Chief Operating Officer at and Global Head of Business Development TCG GreenChem, Inc. He provides industry experience in chemistry, drug development and process research, having previously held positions at Merck & Co. Inc. in Rahway, N.J and in the U.K. for two pharmaceutical companies in the areas of Pharmaceutical Research and Development. His primary areas of focus have been in the design and implementation of efficient synthesis of drug candidates amenable to large scale production. Dr. Armstrong led the development team that designed, developed and implemented the manufacturing process for the new treatment for Type II diabetes, Januvia TM. His team was awarded the Solvias Prize in 2004 (Basel, Switzerland), the IChemE Aztra-Zeneca Award for Green Chemistry and Engineering in 2005 (London, England), Dr. Armstrong has more than 40 publications and holds 10 patents.

Family Relationships

Dr. Anatoly Dritschilo and Peter Dritschilo are father and son. There are no other family relationships among our directors and executive officers.

Involvement in Certain Legal Proceedings

During the past ten years, other than Peter Dritschilo, our President, who filed for personal bankruptcy under Chapter 7 of the U.S. Bankruptcy Code in 2014, no director, executive officer, promoter, or control person of the Company has been involved in the following:

| (1) | A                                                                                                                                      
 petition under the Federal bankruptcy laws or any state insolvency law which was filed by or against, or a receiver, fiscal agent      
 or similar officer was appointed by a court for the business or property of such person, or any partnership in which he was a general  
 partner at or within two years before the time of such filing, or any corporation or business association of which he was an executive 
 officer at or within two years before the time of such filing;                                                                         |
| (2) | Such                                                                                                                                   
 person was convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic violations     
 and other minor offenses);                                                                                                             |
| (3) | Such                                                                                                                                   
 person was the subject of any